Cargando…

Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models

Abnormalities in brains of Alzheimer's disease (AD) patients are thought to start long before the first clinical symptoms emerge. The identification of affected individuals at this ‘preclinical AD’ stage relies on biomarkers such as decreased levels of the amyloid-β peptide (Aβ) in the cerebros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maia, Luis F, Kaeser, Stephan A, Reichwald, Julia, Lambert, Marius, Obermüller, Ulrike, Schelle, Juliane, Odenthal, Jörg, Martus, Peter, Staufenbiel, Matthias, Jucker, Mathias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520655/ https://www.ncbi.nlm.nih.gov/pubmed/25978969 http://dx.doi.org/10.15252/emmm.201505026

Ejemplares similares

Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae
por: Rother, Christine, et al.
Publicado: (2022)

CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles
por: Kaeser, Stephan A., et al.
Publicado: (2021)

Highly potent intracellular membrane-associated Aβ seeds
por: Marzesco, Anne-Marie, et al.
Publicado: (2016)

Signatures of glial activity can be detected in the CSF proteome
por: Eninger, Timo, et al.
Publicado: (2022)

Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009)

Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer’s disease
por: Varvel, Nicholas H., et al.
Publicado: (2015)

Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy
por: Jährling, Nina, et al.
Publicado: (2015)

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice
por: Balakrishnan, Karthikeyan, et al.
Publicado: (2015)

Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey
por: Chan, Anthony W.S., et al.
Publicado: (2022)

Aβ seeds and prions: How close the fit?
por: Rasmussen, Jay, et al.
Publicado: (2017)

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
por: Wagner, Jessica, et al.
Publicado: (2022)

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
por: Boza-Serrano, Antonio, et al.
Publicado: (2022)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Multiple cerebral microbleeds and atypical β-amyloid deposits: A case report
por: Lee, Jin San, et al.
Publicado: (2019)

Prion-like aspects of cerebral amyloidosis
por: Jucker, Mathias, et al.
Publicado: (2013)

Induction of complement proteins in a mouse model for cerebral microvascular Aβ deposition
por: Fan, Rong, et al.
Publicado: (2007)

Amyloid‐β PET and CSF in an autopsy‐confirmed cohort
por: Reimand, Juhan, et al.
Publicado: (2020)

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
por: Remnestål, Julia, et al.
Publicado: (2021)

Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue
por: Kollmer, Marius, et al.
Publicado: (2019)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
por: Mattsson, N, et al.
Publicado: (2013)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Diurnal oscillation of CSF Aβ and other AD biomarkers
por: Lucey, Brendan P., et al.
Publicado: (2017)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
por: Wisch, Julie K., et al.
Publicado: (2023)

Engineering of Thermostable β‐Hydroxyacid Dehydrogenase for the Asymmetric Reduction of Imines
por: Stockinger, Peter, et al.
Publicado: (2020)

Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
por: Wang, Jun, et al.
Publicado: (2022)

TL1A Increases Expression of CD25, LFA-1, CD134 and CD154, and Induces IL-22 and GM-CSF Production from Effector CD4 T-Cells
por: Reichwald, Kirsten, et al.
Publicado: (2014)

CSF circulation and cerebral cortex development
por: Miyan, Jaleel
Publicado: (2009)

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
por: Brier, Matthew R., et al.
Publicado: (2016)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
por: Boumenir, Adla, et al.
Publicado: (2019)

CSF VEGF Was Positively Associated with Neurogranin Independent of β-Amyloid Pathology
por: Huang, Yangping, et al.
Publicado: (2020)

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
por: de Wilde, Arno, et al.
Publicado: (2019)

Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
por: Reimand, Juhan, et al.
Publicado: (2020)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
por: Hansson, Oskar, et al.
Publicado: (2019)

Iatrogenic early onset cerebral amyloid angiopathy 30 years after cerebral trauma with neurosurgery: vascular amyloid deposits are made up of both Aβ40 and Aβ42
por: Giaccone, Giorgio, et al.
Publicado: (2019)

Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
por: Kantarci, Kejal, et al.
Publicado: (2016)

Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brain
por: Marinelli, Rita, et al.
Publicado: (2020)

Characterization of Amyloid-β Deposits in Bovine Brains
por: Vallino Costassa, Elena, et al.
Publicado: (2016)

Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy()
por: Keable, Abby, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s1vag6phrnueo8o406vtkj4ao9